Literature DB >> 4016022

The psychosocial impact of a progressive physical handicap and terminal illness (Duchenne muscular dystrophy) on adolescents and their families.

R A Witte.   

Abstract

This paper reports in narrative style on a sample of 13-16-year-old Duchenne muscular dystrophy adolescents in a residential setting in the UK. The terminally ill dystrophic boys' physical handicaps were noticed at about five years of age. In-depth interviews were conducted with parents, while projective assessment and psychodrama were used with the boys. Findings for this paper draw heavily on family interviews. Not surprisingly, the Duchenne boys evinced significant isolation from the mainstream of normal culture. The parents of the terminal group showed marked preoccupation with their sons, great stress and diminished expression of enjoyment. The Duchenne adolescents raised the issue of handicap surprisingly often with their parents, suggesting their great need to acknowledge their disease with parents. Their parents, however, evinced marked difficulty in responding to death issues with the boys - a reaction which leaves the boys alone and the parents guilty. These observations on the family are discussed in the context of a family identification process.

Entities:  

Mesh:

Year:  1985        PMID: 4016022     DOI: 10.1111/j.2044-8341.1985.tb02632.x

Source DB:  PubMed          Journal:  Br J Med Psychol        ISSN: 0007-1129


  2 in total

1.  Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health.

Authors:  Roxanna M Bendixen; Claudia Senesac; Donovan J Lott; Krista Vandenborne
Journal:  Health Qual Life Outcomes       Date:  2012-05-22       Impact factor: 3.186

2.  Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life?

Authors:  Susan Sienko; Cathleen Buckon; Eileen Fowler; Anita Bagley; Loretta Staudt; Mitell Sison-Williamson; Kathy Zebracki; Craig M McDonald; Michael Sussman
Journal:  PLoS Curr       Date:  2016-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.